ADC Therapeutics SA Share Price
NASDAQ: ADCTHealthcare
Live ADC Therapeutics SA Share Price Chart
O H L
ADC Therapeutics SA Performance Overview
Days Range
▼
$1.06Low
$1.07High
Markets Today
| Previous Close | $1.06 |
|---|---|
| Open | $1.06 |
| Volume | 135,543 |
| Day's Range | $1.06 - $1.07 |
| 52W Range | $0.78 - $4.98 |
| Market Cap | $134.05 M |
Historical Performance
| 1M Returns | +2.91 |
|---|---|
| 3M Returns | -2.75 |
| 6M Returns | -73.57 |
| 1Y Returns | -68.73 |
| 5Y Returns | -96.33 |
| 10Y Returns | NA |
ADC Therapeutics SA Fundamentals
| Market Cap | $134.05 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $81.36 M |
| ROE TTM | N/A |
| EPS TTM | $-0.73 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-107.67 M |
| Profit Margin | -175.31 |
| Market Cap | $134.05 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $81.36 M |
| ROE TTM | N/A |
| EPS TTM | $-0.73 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-107.67 M |
| Profit Margin | -175.31 |
ADC Therapeutics SA Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $23.03 M | $18.84 M | $16.43 M | $23.06 M | $20.85 M | $19.25 M |
| Gross Profit + | $20.97 M | $18.00 M | $15.22 M | $21.36 M | $17.24 M | $16.90 M |
| Operating Income | -$28.46 M | -$44.15 M | -$30.97 M | -$17.92 M | -$25.25 M | -$25.41 M |
| EBITDA | -$28.46 M | -$31.06 M | -$30.59 M | -$18.27 M | -$25.25 M | -$22.74 M |
| Interest Expense | -$12.23 M | -$13.00 M | -$13.39 M | -$13.01 M | -$12.35 M | -$13.51 M |
| Depreciation | $0 | $13.09 M | $378.00 K | -$348.00 K | $0 | $2.67 M |
| Income Before Tax | -$38.44 M | -$55.39 M | -$40.97 M | -$6.81 M | -$32.97 M | -$16.57 M |
| Income Tax Expense | $165.00 K | $1.25 M | $0 | -$404.00 K | $0 | $0 |
| Net Income + | -$38.60 M | -$56.65 M | -$40.97 M | -$6.41 M | -$32.97 M | -$16.57 M |
| Net Profit Margin | -167.59% | -300.68% | -249.38% | -27.8% | -158.11% | -86.06% |
ADC Therapeutics SA Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $8.44 M | $9.75 M | $9.76 M | $11.08 M | $11.23 M | $11.25 M |
| Reserve & Surplus | -$1.53 B | -$1.59 B | -$1.63 B | -$1.64 B | -$1.67 B | -$1.69 B |
| Non-Current Liabilities | $452.97 M | $456.14 M | $465.90 M | $438.82 M | $440.25 M | $421.25 M |
| Current Liabilities | $57.79 M | $64.60 M | $62.04 M | $70.16 M | $67.63 M | $86.33 M |
| Total Liabilities | $510.76 M | $520.75 M | $527.94 M | $508.98 M | $507.87 M | $507.58 M |
| Fixed Assets | $5.16 M | $1.00 K | $0 | $0 | $0 | $0 |
| Current Assets | $257.99 M | $318.75 M | $287.15 M | $306.33 M | $276.77 M | $261.71 M |
| Total Assets | $272.54 M | $321.56 M | $289.76 M | $323.15 M | $291.50 M | $279.38 M |
ADC Therapeutics SA Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$38.60 M | -$56.65 M | -$40.97 M | -$6.41 M | -$32.97 M | -$16.57 M |
| Operating Cash Flow | -$56.33 M | -$24.09 M | -$29.63 M | -$31.12 M | -$29.71 M | -$11.81 M |
| Investing Cash Flow | -$264.00 K | $0 | $0 | $659.00 K | -$32.00 K | $0 |
| Financing Cash Flow | $271.00 K | $93.78 M | -$198.00 K | $57.09 M | -$583.00 K | -$99.00 K |
| Change in Cash | -$56.33 M | $69.70 M | -$29.83 M | $26.63 M | -$30.32 M | -$11.91 M |
ADC Therapeutics SA Return Calculator
The ADC Therapeutics SA stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$371
Invested Amount$10,000
Est. Returns$-9,629
About ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Popular Stocks
FAQs
What is the share price of ADC Therapeutics SA today?
ADC Therapeutics SA (ADCT) share price as of September 18, 2026 is $1.07. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of ADC Therapeutics SA?
Yes, Indian Investors can invest in the ADC Therapeutics SA (ADCT) Share by opening an international trading account with Angel One.
How can I purchase ADC Therapeutics SA shares in India?
Purchasing ADC Therapeutics SA (ADCT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying ADC Therapeutics SA (ADCT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of ADC Therapeutics SA?
Yes, you can purchase fractional shares of ADC Therapeutics SA (ADCT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of ADC Therapeutics SA?
The market capitalization of ADC Therapeutics SA on September 18, 2026, is $134.05 M.
In which sector ADC Therapeutics SA belongs?
ADC Therapeutics SA operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in ADC Therapeutics SA stocks?
In order to invest in ADC Therapeutics SA (ADCT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
